Role of bosentan in patients with chronic venous thromboembolic pulmonary hypertension;Efectividad del bosentán en el tratamiento de la hipertensión pulmonar debida a tromboembolia venosa crónica

Medicina Clinica

Volumn 128, Issue 1, 2007, Pages 12-14

  Segovia Cubero, Javier ^a   Ortiz Uribe, Juan Camilo ^a   Gómez Bueno, Manuel ^a   Moñivas Palomero, Vanessa ^a   González González, Magdalena ^a   Rivera, Luis Alonso Pulpón ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Bosentan; Chronic pulmonary embolism; Thromboembolic pulmonary hypertension

Indexed keywords

BOSENTAN;

ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; FOLLOW UP; HUMAN; LUNG VASCULAR RESISTANCE; PROGNOSIS; PULMONARY HYPERTENSION; TREATMENT OUTCOME; TREATMENT RESPONSE; VENOUS THROMBOEMBOLISM;

EID: 33846902098     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13096947     Document Type: Article

References (10)

1. Dartevelle P, Fadel E, St Mussot S, Chapelier A, Hervé P, De Perrot M, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J. 2004;23:637-48.
2. Bonderman D, Nowotny R, Skoro-Sajer N, Jakowitsch J, Adlbrecht C, Klepetko W, et al. Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension. Chest. 2005;128:2599-603.
3. Nagaya N, Sasaki N, Ando M, Ogino H, Sakamaki F, Kyotani S, et al. Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Chest. 2003;123:338-43.
4. Olschewski H, Simonneau G, Galié N, HigenbottamT, Naeije R, Rubin LJ, et al. Inhaled Iloprost for severe pulmonary hypertension. N Engl J Med. 2002;347:322-9.
5. Ghofrani HA, Schermuly RT, Rose F, Wiedemann R, Kohstall MG, Kreckel A, et al. Sildenafil for long-term treatment of non operable chronic thromboembolic pulmonary hypertension. Am J Resp Crit Care Med. 2003;167:1139-41.
6. Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med. 2002;346:896-903.
7. Hoeper MM, Kramm T, Wilkens H, Schulze C, Schafers HJ, Welte T, et al. Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension. Chest. 2005;128:2363-7.
8. Hughes R, George P, Parameshwar J, Cafferty F, Dunning J, Morrell NW, et al. Bosentan in inoperable chronic thromboembolic pulmonary hypertension [carta]. Thorax. 2005;60:707.
9. Barst RJ, McGoon M, McLaughlin V, Tapson V, Rich S, Rubin L, et al. Beraprost therapy for pulmonary arterial hypertension. J Am Coll Cardiol. 2003;41:2119-25.
10. Leuchte HH, Holzapfel M, Baumgartner RA, Neurohr C, Vogeser M, Behr J. Characterization of brain natriuretic peptide in long-term follow-up of pulmonary arterial hypertension. Chest. 2005;128:2368-74.